Showing results (11-20 of 242) with videos related to

Sort By:
Pageof 25
Hematology/Oncology Clinics of North America|April 4, 2015
First-line treatment of metastatic disease: cisplatin-ineligible patientsRichard Cathomas, Maria De Santis, Matthew D Galsky
Arthritis Research & Therapy|July 5, 2011
Liver involvement in subjects with rheumatic diseaseCarlo Selmi, Maria De Santis, M Eric Gershwin
Aktuelle Urologie|March 28, 2022
[Update on systemic treatment of urothelial cancer: therapy in transition]Robert Tauber, Gunhild von Amsberg, Maria De Santis
European Urology Focus|April 6, 2024
Front-line Platinum Continues To Have a Role in Advanced Bladder CancerUrsula M Vogl, Irene Testi, Maria De Santis
The Israel Medical Association Journal : IMAJ|September 12, 2019
Rheumatoid Factors in Hepatitis B and C Infections: Connecting Viruses, Autoimmunity, and CancerJakub Moll, Natasa Isailovic, Maria De Santis, et al.
European Urology|September 1, 2020
Precision Oncology for Metastatic Prostate Cancer: Translation into PracticeMaria De Santis, Nicolas Mottet, Philip Cornford, et al.
Disease Markers|February 8, 2011
Infectious agents and xenobiotics in the etiology of primary biliary cirrhosisCarlo Selmi, Maria De Santis, Francesca Cavaciocchi, et al.
Cancer Immunology, Immunotherapy : CII|May 31, 2015
Targeted treatment of metastatic castration-resistant prostate cancer with sipuleucel-T immunotherapyPeter F Mulders, Maria De Santis, Thomas Powles, et al.
Frontiers in Medicine|April 3, 2023
Interstitial lung disease associated with inflammatory myositis: Autoantibodies, clinical phenotypes, and progressive fibrosisAngela Ceribelli, Antonio Tonutti, Natasa Isailovic, et al.
Seminars in Arthritis and Rheumatism|January 11, 2025
Established and novel insights to guide cancer assessment in patients with idiopathic inflammatory myopathiesAngela Ceribelli, Antonio Tonutti, Natasa Isailovic, et al.
Pageof 25